Request Your Free White Paper!
"Enabling Translational Medicine with Business Intelligence"
Learn about technology solutions for translational research and the requirements for a collaborative platform that leverages in-house expertise, speaks to both scientists and IT staff and links all end users across departments.
The shift towards translational medicine depends on vendors offering technology solutions that are aligned to the unique needs of the pharmaceutical industry. BI tools, such as data analytics, must reflect domain expertise and encompass both the research and development (R&D) and clinical departments of a pharmaceutical company. This paper will argue the following:
This white paper is written by Datamonitor, Sponsored by InforSense.
- Market pressures are driving pharmaceutical firms to embrace translational medicine;
- Translational research requires BI technology components;
- BI solutions must reflect domain expertise for the drug development process; and
- Four technology features add value to a BI solution for translational medicine.
Offered Free by: InforSense
Other Resources from: